Beckman Coulter Upgraded by JP Morgan

Jan 04, 2010

NEW YORK (GenomeWeb News) – Investment bank JP Morgan has upgraded Beckman Coulter's stock to "overweight" from "neutral," due to the firm's long-range earnings forecast.

In mid-December, Beckman Coulter set a preliminary 2010 guidance for adjusted earnings per share of between $4.40 and $4.55, which was just below analysts' consensus estimate of $4.56.

JP Morgan also set a 12-month price target on the stock of $75.

In early Monday trade on the New York Stock Exchange, shares of Beckman Coulter were up around 2 percent at $67.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Mice With Same-Sex Parents Born

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Don't Touch

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

Hong Kong's Research Funding Boost

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

This Week in Science

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Featured White Papers

Potential Pitfalls to Life Science Product Launch

Freeze-drying - a manufacturing approach to increase the stability of in vitro diagnostic (IVD) assays

Point of Care Testing Using Smartphone Diagnostic Readers - Download FAQ Guide

Contract Manufacturing in Biotech: Turning Your Supply Chain Into a Competitive Differentiator

Oct

23

Featured Webinar

Perspectives on Small RNA Sequencing: Challenges and Complications of Small RNA Library Prep

This webinar will address a range of methods for optimizing small RNA library preparation.

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Nov

29

Featured Webinar

Glass or Polymer? A Comparison for Use in In Vitro Diagnostic Biochips

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Main menu